Online: 16 August 2023 (20:23:59 CEST)
Show abstract| Download PDF| Share
Online: 9 May 2018 (05:50:26 CEST)
Show abstract| Download PDF| Share
Online: 8 March 2024 (04:33:46 CET)
Show abstract| Download PDF| Share
Online: 26 March 2024 (07:27:48 CET)
Online: 17 September 2024 (11:40:20 CEST)
Show abstract| Download PDF| Share
Online: 27 December 2023 (05:27:40 CET)
Show abstract| Download PDF| Share
Online: 7 July 2023 (05:50:04 CEST)
Online: 27 September 2024 (07:50:26 CEST)
Show abstract| Download PDF| Share
Online: 3 May 2024 (11:22:34 CEST)
Online: 26 May 2023 (10:47:14 CEST)
Show abstract| Download PDF| Share
Online: 23 May 2023 (08:33:02 CEST)
Show abstract| Download PDF| Share
Online: 23 November 2023 (09:36:38 CET)
Show abstract| Download PDF| Share
Online: 15 January 2019 (09:30:09 CET)
Show abstract| Download PDF| Share
Online: 11 September 2018 (05:10:40 CEST)
Show abstract| Download PDF| Share
Online: 24 August 2023 (02:20:25 CEST)
Show abstract| Download PDF| Share
Online: 21 April 2023 (10:05:20 CEST)
Show abstract| Download PDF| Share
Online: 19 April 2023 (13:36:52 CEST)
Show abstract| Download PDF| Share
Online: 27 June 2022 (08:01:22 CEST)
Show abstract| Download PDF| Share
Online: 21 June 2021 (10:21:57 CEST)
Show abstract| Download PDF| Share
Online: 7 September 2018 (13:22:19 CEST)
Show abstract| Download PDF| Share
Online: 24 July 2024 (07:02:17 CEST)
Show abstract| Download PDF| Share
Online: 3 June 2024 (14:23:23 CEST)
Online: 31 August 2023 (12:35:42 CEST)
Show abstract| Download PDF| Share
Online: 19 July 2023 (03:10:13 CEST)
Show abstract| Download PDF| Share
Online: 2 August 2022 (12:15:03 CEST)
Show abstract| Download PDF| Share
Working Paper ARTICLE
Online: 3 March 2021 (14:16:48 CET)
Online: 10 February 2021 (07:54:28 CET)
Show abstract| Download PDF| Share
Online: 16 September 2020 (03:25:43 CEST)
Show abstract| Download PDF| Share
Online: 6 August 2024 (03:39:27 CEST)
Online: 15 December 2023 (14:52:59 CET)
Show abstract| Download PDF| Share
Online: 26 October 2023 (03:26:26 CEST)
Show abstract| Download PDF| Share
Online: 23 October 2023 (09:54:08 CEST)
Show abstract| Download PDF| Share
Online: 31 March 2023 (03:13:00 CEST)
Show abstract| Download PDF| Share
Online: 26 August 2019 (12:34:43 CEST)
Show abstract| Download PDF| Share
Online: 18 June 2018 (13:38:56 CEST)
Show abstract| Download PDF| Share
Online: 18 December 2016 (10:30:52 CET)
Show abstract| Download PDF| Share
Online: 2 October 2023 (04:07:20 CEST)
Online: 27 September 2020 (04:12:17 CEST)
Show abstract| Download PDF| Share
Online: 1 April 2019 (13:51:53 CEST)
Show abstract| Download PDF| Share
Online: 27 December 2018 (05:28:16 CET)
Show abstract| Download PDF| Share
Online: 27 March 2017 (12:01:25 CEST)
Online: 27 February 2024 (14:00:28 CET)
Online: 26 March 2020 (14:27:39 CET)
Show abstract| Download PDF| Share
Online: 31 May 2023 (07:52:28 CEST)
Online: 16 April 2019 (09:54:03 CEST)
Online: 3 March 2021 (10:07:48 CET)
Online: 6 February 2024 (17:10:47 CET)
Show abstract| Download PDF| Share
Online: 2 February 2024 (04:47:08 CET)
Online: 24 July 2024 (15:56:02 CEST)
Show abstract| Download PDF| Share
Online: 12 June 2024 (11:58:47 CEST)
Show abstract| Download PDF| Share
Online: 28 February 2024 (00:07:30 CET)
Show abstract| Download PDF| Share
Online: 24 January 2024 (02:53:32 CET)
Show abstract| Download PDF| Share
Online: 6 September 2021 (11:46:54 CEST)
Show abstract| Download PDF| Share
Online: 3 February 2020 (13:34:02 CET)
Show abstract| Download PDF| Share
Subject: Chemistry And Materials Science, Biomaterials Keywords: There are many molecules used as drug carrier. TUD-1 is a newly synthesized mesoporous silica (SM) molecule possess two important features; consists of mesoporous so it is very suitable to be drug carrier in addition to that it has the ability to induce apoptosis in cancer cells. However, the effect of TUD-1 appears to act as cell death inducer, regardless of whether it is necrosis or apoptosis. Unfortunately, recent studies indicate that a proportion of cells undergo necrosis rather than apoptosis, which limits the use of TUD-1 as a secure treatment. On the other hand, lithium considered as necrosis inhibitor element. Hence, current study based on the idea of production a new Li/TUD-1 by incorporated mesoporous silica (TUD-1 type) with lithium in order to produce a new compound that has the ability to activate apoptosis by mesoporous silica (TUD-1 type) and at the same time can inhibit the activity of necrosis by lithium. Herein, lithium was incorporated in TUD-1 mesoporous silica by
Online: 4 October 2018 (15:54:02 CEST)
Show abstract| Download PDF| Share
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.